Presystemic metabolism of albendazole: Experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumen

Drug Metabolism and Disposition

Volumn 27, Issue 6, 1999, Pages 736-740

  Redondo, P A ^a   Alvarez A I ^a   Garcia, J L ^a   Larrode O M ^a   Merino, G ^a   Prieto, J G ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; CYTOCHROME P450; POLYSORBATE 80; TAUROCHOLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; ENANTIOMER; FIRST PASS EFFECT; HUMAN; INTESTINE EPITHELIUM; JEJUNUM; PRIORITY JOURNAL; RAT; SMALL INTESTINE ABSORPTION; STEREOSPECIFICITY;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BIOTRANSFORMATION; INTESTINAL ABSORPTION; INTESTINES; MALE; MICROSOMES; OXIDOREDUCTASES; RATS; RATS, WISTAR; STEREOISOMERISM;

ANIMALIA;

EID: 0033020066     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Aix L, Rey-Grobellet X, Larrieu G, Lesca P and Galtier P (1994) Thiabendazole is an inducer of cytochrome P4501A1 in cultured rabbit hepatocytes. Biochem Biophys Res Commun 202:1483-1489.
2. Albers R and Rosenberg DW (1991) In vivo intestinal metabolism of 7-ethoxycoumarin in the rat: Production and distribution of phase I and II metabolites in the isolated, perfused intestinal loop. Toxicol Appl Pharmacol 109:507-513.
3. Alvinerie M and Galtier P (1984) Simultaneous determination of albendazole and its principal metabolites in plasma by normal phase high-performance liquid chromatography. J Pharm Biomed Anal 2:73-79.
4. Berry C, Stellon A and Hallinan T (1975) Guinea pig liver microsomal UDP-glucuronyltransferase: Compartmented or phospholipid-constrained? Biochim Biophys Acta 403:335-344.
5. Choi YM, Chung SM and Chiou WL (1995) First-pass accumulation of salicylic acid in gut tissue after absorption in anesthetized rat. Pharm Res 12:1323-1327.
6. del Estal JL, Alvarez AI, Villaverde C, Coronel P, Fabra S and Prieto JG (1991) Effect of surfactants on albendazole absorption. J Pharm Biomed Anal 9:1161-1164.
7. Delatour P, Benoit E, Bessé S and Boukraa A (1991) Comparative enantioselectivity in the sulfoxidation of albendazole in man, dogs and rats. Xenobiotica 21:217-221.
8. Didier ES (1997) Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro. Antimicrob Agents Chemother 41:1541-1546.
9. Doluisio JT, Billups NF, Dittert LW, Sugita ET and Swintosky JV (1969) Drug absorption I: An in situ rat gut technique yielding realistic absorption rates. J Pharm Sci 58:1196-1200.
10. Fasco MJ, Silkworth JB, Dunbar DA and Kaminsky LS (1993) Rat small intestinal cytochromes P450 probed by warfarin metabolism. Mol Pharmacol 43:226-233.
11. Galtier P, Alvinerie M and Delatour P (1986) In vitro sulfoxidation of albendazole by ovine liver microsomes: Assay and frequency of various xenobiotics. Am J Vet Res 47:447-450.
12. Gil-Grande LA, Rodríguez-Caabeiro F, Prieto JG, Sánchez-Ruano JJ, Brasa C, Aguilar L, García-Hoz F, Casado N, Bárcena R, Alvarez AI and Dal-Ré R (1993) Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 342:1269-1272.
13. Gleizes C, Eeckhoutte C, Pineau T, Alvinerie M and Galtier P (1991) Inducing effect of oxfendazole on cytochrome P450IA2 in rabbit liver. Consequences on cytochrome P450 dependent monooxygenases. Biochem Pharmacol 41:1813-1820.
14. Goon D and Klaassen CD (1989) Dosage-dependent absorption of cadmium in the rat intestine measured in situ. Toxicol Appl Pharmacol 100:41-50.
15. Jones MN (1992) Surfactant interactions with biomembranes and proteins. Chem Society Rev (002):127-136.
16. Kakemi K, Sezaki H, Konishi R, Kimura T and Okita A (1970) Effect of bile salts on the gastrointestinal absorption of drugs. II. Mechanism of the enhancement of the intestinal absorption of sulfaguanidine by bile salts. Chem Pharm Bull 18:1034-1039.
17. Kelly P, Lungu F, Keane E, Baggaley R, Kazembe F, Pobee J and Farthing M (1996) Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: A randomised double blind controlled trial. Br Med J 312:1187-1191.
18. Kolars JC, Stetson PL, Rush BD, Ruwart MJ, Schmiedlin-Ren P, Duell EA, Voorhees JJ and Watkins PB (1992) Cyclosporine metabolism by P450IIIA in rat enterocytes. Another determinant of oral bioavailability? Transplantation 53:596-602.
19. Kulkarni AP and Hodgson E (1982) Mouse liver microsomal hexose-6-phosphate dehydrogenase. NADPH generation and utilization in monooxygenation reactions. Biochem Pharmacol 31:1131-1137.
20. Larsen-Su S and Willians DE (1996) Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing tnonooxygenase form 1 in rat liver and intestine. Drug Metab Dispos 24:927-931.
21. Lawrenz VA, Eglit S and Kroker R (1992) Investigations on metabolism of albendazole in the isolated perfused gut of rats. Dtsch Tieräztl Wschr 99:416-418.
22. Lennernäs H and Regårdh CG (1993) Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat. Pharm Res (NY) 10:727-731.
23. Martín-Villodré A, Plá-Delfina JM, Moreno J, Pérez-Buendía MD, Millares J, Collado EF, Sánchez-Moyano E and Del Pozo A (1986) Studies on the reliability of a bihyperbolic functional absorption model. I. Ring-substituted anilines. J Pharmacokinet Biopharm 14:615-633.
24. Miller DL and Schedl HP (1972) Nonabsorbed indicators: a comparison of phenol red and inulin-14C and effects of perfusion technique. Gastroenterology 62:48-55.
25. Miyamoto E, Tsuji A and Yamana T (1983) Effects of surfactants on the gastrointestinal absorption of beta-lactam antibiotics in rats. J Pharm Sci 72:651-654.
26. Moroni P, Buronfosse T, Longin-Sauvageon C, Delatour P and Benoit E (1995) Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes. Drug Metab Dispos 23:106-165.
27. Ravis W, Wang JS and Feldman S (1983) Intestinal absorption and metabolism of 6-mercaptopurine in the rat small intestine. Biochem Pharmacol 33:443-448.
28. Redondo PA, Alvarez AI, García JL, Villaverde C and Prieto JG (1998) Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats. Biopharm Drug Dispos 19:65-70.
29. Rey-Grobellet X, Ferre N, Eeckhoutte C, Larrieu G, Pineau T and Galtier P (1996) Structural requirements for the induction of cytochromes P450 by benzimidazole anthelmintic derivatives in cultures rabbit hepatocytes. Biochem Biophys Res Commun 220:789-794.
30. Souhaili-El Amri H, Fargetton X, Benoit E, Totis M and Batt AM (1988) Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics. Toxicol Appl Pharmacol 92:141-149.
31. Villaverde C, Alvarez AI, Redondo P, Voces J, Del Estal JL and Prieto JG (1995) Small intestinal sulphoxidation of albendazole. Xenobiotica 25:433-441.
32. Watkins PB (1992) Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin North Am 10:511-526.
33. Watkins PB, Wrighton SA, Schuetz EG, Molowa DT and Guzelian PS (1987) Identification of glucocorticoid-inducible cytochromes P450 in the intestinal mucosa of rats and man. J Clin Invest 80:1029-1036.
34. Weiser MM (1973) Intestinal epithelial cell surface membrane glycoprotein synthesis I. An indicator of cellular differentiation. J Biol Chem 248:2536-2541.
35. Yasuhara M, Kurosaki Y, Kimura T and Sezaki H (1984) Drug elimination function of rat small intestine: Metabolism and intraluminal excretion. Biochem Pharmacol 33:3131-3136.
36. Yun Ch, Song M and Kim H (1997) Conformational change of cytochrome P450 1 A2 induced by phospholipids and detergents. J Biol Chem 272:19725-19730.